Apollon Wealth Management LLC Acquires 132 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Apollon Wealth Management LLC boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 11.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,304 shares of the biotechnology company’s stock after acquiring an additional 132 shares during the quarter. Apollon Wealth Management LLC’s holdings in Axon Enterprise were worth $521,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Foundations Investment Advisors LLC purchased a new stake in Axon Enterprise during the 3rd quarter valued at $221,000. Sequoia Financial Advisors LLC lifted its holdings in shares of Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after acquiring an additional 81 shares during the last quarter. Axxcess Wealth Management LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter worth about $814,000. Jag Capital Management LLC raised its position in Axon Enterprise by 9.7% in the 3rd quarter. Jag Capital Management LLC now owns 56,086 shares of the biotechnology company’s stock worth $22,412,000 after purchasing an additional 4,954 shares during the period. Finally, Versor Investments LP bought a new stake in Axon Enterprise in the third quarter worth about $651,000. 79.08% of the stock is owned by institutional investors.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of Axon Enterprise stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The trade was a 2.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total value of $380,990.00. Following the sale, the director now owns 27,259 shares of the company’s stock, valued at approximately $10,385,406.41. This represents a 3.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 411,006 shares of company stock valued at $161,360,618 in the last 90 days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

AXON opened at $599.35 on Friday. The firm has a market capitalization of $45.70 billion, a PE ratio of 154.87, a price-to-earnings-growth ratio of 15.10 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business’s 50-day moving average is $438.79 and its two-hundred day moving average is $357.57. Axon Enterprise, Inc. has a 1 year low of $220.78 and a 1 year high of $624.84.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Needham & Company LLC increased their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Robert W. Baird lifted their target price on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Barclays upped their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Finally, Craig Hallum upped their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.